Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This example shows a sample report table, trial design, and results dataset for study 123 for the determination of the in vitro genotoxicity potential of tobacco products using the in vitro micronucleus assay

Jira
showSummaryfalse
serverIssue Tracker (JIRA)
serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
keyTOBA-332
Jira
showSummaryfalse
serverIssue Tracker (JIRA)
serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45
keyTOBA-135
  JirashowSummaryfalseserverIssue Tracker (JIRA)serverId85506ce4-3cb3-3d91-85ee-f633aaaf4a45keyTOBA-127

Expand
titleSample Report Table for Study 123

...

Dataset wrap
Nametx
Rowcaps
Rows 1-17:

Show the experimental parameters that are common for table 1 of study 123.

Rows 18, 25: 

Show that sets A1 and A2 each have a parent set code of A. As a child of set A, each of these sets inherit the test conditions of set A.

Rows 18-24:

Show trial set parameters and values that comprise the test conditions for trial set A1. Set A1 is the data for the negative control (concentration 0) with short-term exposure and metabolic activation S9.  The applicant has chosen to given a long name (SET) equal to "ST+S9_C0".

Set A1 is associated with the first row in the sample report table for study 123.

Rows 25-31:

Show trial set parameters and values that comprise the test conditions for trial set A2. Set A2 is the data for the short-term exposure with metabolic activation S9 at a concentration of 1250 ug/ml. The applicant has chosen to give the set a long name (SET) equal to "ST+S9_C1250".

Set A2 is associated with the second row in the sample report table for study 123.

Dataset2
RowSTUDYIDGNTXAIDDOMAINSETCDSETTXSEQTXPARMCDTXPARMTXVAL

1

123MNvitTXAST+S9

1

METACTMetabolic Activation+S9
2123MNvitTXAST+S92METACTFLY/N presence of metabolic activationY
3123MNvitTXAST+S93TRTDMINIn vitro Treatment Duration Minimum3
4123MNvitTXAST+S94TRTDTRGIn vitro Treatment Duration Target3.5
5123MNvitTXAST+S95TRTDMAXIn vitro Treatment Duration Maximum4
6123MNvitTXAST+S96TRTDUIn vitro Treatment Duration UnitHOURS
7123MNvitTXAST+S97RCVDMINRecovery Duration Minimum23.5
8123MNvitTXAST+S98RCVDTRGRecovery Duration Target24
9123MNvitTXAST+S99RCVDMAXRecovery Duration Maximum24.5
10123MNvitTXAST+S910RCVDURecovery Duration UnitHOURS
11123MNvitTXAST+S911INCBTMPIncubation Temperature37
12123MNvitTXAST+S912INCBTMPUIncubation Temperature UnitC
13123MNvitTXAST+S913HUMIDAtmospheric Relative Humidity Percent50
14123MNvitTXAST+S914ATMCO2Atmospheric CO2 Percent5
15123MNvitTXAST+S915

SPTOBID

Applicant-defined tobacco identifier

CIG01a
16123MNvitTXAST+S916EXPTYP

Exposure Type

Submerged
17123MNvitTXAST+S917SAMTYP

Sample Type

Total Particulate Matter in DMSO
18123MNvitTXA1ST+S9_C0

1

PSETCD

Parent Set Code

A
19123MNvitTXA1ST+S9_CO2INTRVN

Name of the Intervention Article

Tobacco ProdA
20123MNvitTXA1ST+S9_C03ITVTYPE

type of intervention article

Negative Control
21123MNvitTXA1ST+S9_C04ITVCONCConcentration of intervention article0
22123MNvitTXA1ST+S9_C05ITVCONCUConcentration Unitug/ml
23123MNvitTXA1ST+S9_C06

SPDEVID

Applicant-defined device identifierPUFFMASTER3K
24123MNvitTXA1ST+S9_C07

DUREFID

Smoke RegimenMedium Intensity Regimen
25123MNvitTXA2ST+S9_C1250

1

PSETCD

Parent Set Code

A
26123MNvitTXA2ST+S9_C12502INTRVN

Name of the Intervention Article

Tobacco ProdA
27123MNvitTXA2ST+S9_C12503ITVTYPE

type of intervention article

Product
28123MNvitTXA2ST+S9_C12504ITVCONCConcentration of intervention article1250
29123MNvitTXA2ST+S9_C12505ITVCONCUConcentration Unitug/ml
30123MNvitTXA2ST+S9_C12506SPDEVIDApplicant-defined device identifierPUFFMASTER2023
31123MNvitTXA2ST+S9_C12507DUREFIDSmoke RegimenHigh Intensity Regimen
Dataset wrap
Namerelref
Rowcaps
Row 1:Shows the value of REFID=C0. This REFID refers to the trial set with a SETCD of "A1", as defined in the TX dataset. LEVEL=1 and LVLDESC="EXPERIMENTAL UNIT/TRIAL SET" indicates this identifier is referring to both the experimental unit and the unit to which the treatment is applied, and to the entire trial set.
Rows 2-5:Show the values of 4 observational units (C0_Count1 through C0_Count4) that are within the parent experimental unit, REFID=C0. In this example assay, these observational units are also all within the same trial set, as defined in the TX dataset.
Row 6:Shows the value of REFID=C1250. This REFID refers to the trial set with a SETCD of "A2", as defined in the TX dataset. LEVEL=1 and LVLDESC="EXPERIMENTAL UNIT/TRIAL SET" indicates this identifier is referring to both the experimental unit and the unit to which the treatment is applied, and to the entire trial set.
Rows 7-10:Show the values of 4 observational units (C1250_Count1 through C1250_Count4) that are within the parent experimental unit, REFID=C0. In this example assay, these observational units are also all within the same trial set, as defined in the TX dataset.
Dataset2
tableidrelref

Row

STUDYID

GNTXAID

SETCD

REFID

PARENT

LEVEL

LVLDESC

1

123

MNvit

A1

C0
1

EXPERIMENTAL UNIT/TRIAL SET

2

123

MNvit

A1

C0-Count1C02OBSERVATIONAL UNIT

3

123

MNvit

A1

C0-Count2C02OBSERVATIONAL UNIT

4

123

MNvit

A1

C0-Count3C02OBSERVATIONAL UNIT

5

123

MNvit

A1

C0-Count4C02OBSERVATIONAL UNIT

6

123

MNvit

A2C1250
1EXPERIMENTAL UNIT/TRIAL SET
7123

MNvit

A2C1250-Count1C12502OBSERVATIONAL UNIT
8123

MNvit

A2C1250-Count2C12502OBSERVATIONAL UNIT
9123

MNvit

A2C1250-Count3C12502OBSERVATIONAL UNIT
10123

MNvit

A2C1250-Count4C12502OBSERVATIONAL UNIT
Dataset wrap
Namegt
Rowcaps

Rows 1-3, 8:

Show percentage result values that apply to GTREFID=C0. REFID=C0, as shown in the RELREF dataset, relates this data to the trial set in the first row of table 1 in the sample report table for study 123.
Rows 4-7:Show the 4 micronucleated cell counts for the observational units with GTREFID from C0-Count1 through C0-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the RELREF dataset.

Rows 9-11, 16:

Show percentage result values that apply to GTREFID=C1250. REFID=C1250, as shown in the RELREF dataset, relates this data to the trial set in the second row of table 1 in the sample report table for study 123.
Rows 12-15:Show the 4 micronucleated cell counts for the observational units with GTREFID from C1250-Count1 through C1250-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the RELREF dataset.
Dataset2
RowSTUDYIDGNTXAIDDOMAIN

GTREFID

GTSEQGTTESTCDGTTESTGTCELLEVGTORRESGTORRESU

GTCOLSRT

GTSTRESCGTSTRESNGTSTRESUGTDTC
1123MNvitGTC01RICCRelative Increase in Cell Count1540%
00%2022-05-25
2123MNvitGTC02RCCRelative Cell Count1540%
00%2022-05-25
3123MNvitGTC03RPDRelative Population Doubling1540%
00%2022-05-25
4123MNvitGTC0-Count14MNCEMicronucleated Cells220515Cells
1515Cells2022-05-25
5123MNvitGTC0-Count25MNCEMicronucleated Cells247413Cells
1313Cells2022-05-25
6123MNvitGTC0-Count36MNCEMicronucleated Cells275817Cells
1717Cells2022-05-25
7123MNvitGTC0-Count47MNCEMicronucleated Cells266912Cells
1212Cells2022-05-25
8123MNvitGTC08MNCECEMicronucleated Cells/Total Cells
0.57%
0.570.57%2022-05-25
9123MNvitGTC12501RICCRelative Increase in Cell Count13415.7%
15.715.7%2022-05-25
10123MNvitGTC12502RCCRelative Cell Count13413.0%
13.013.0%2022-05-25
11123MNvitGTC12503RPDRelative Population Doubling1347.9%
7.97.9%2022-05-25
12123MNvitGTC1250-Count14MNCEMicronucleated Cells326620Cells
2020Cells2022-05-25
13123MNvitGTC1250-Count25MNCEMicronucleated Cells219017Cells
1717Cells2022-05-25
14123MNvitGTC1250-Count36MNCEMicronucleated Cells275813Cells
1313Cells2022-05-25
15123MNvitGTC1250-Count47MNCEMicronucleated Cells271421Cells
2121Cells2022-05-25
16123MNvitGTC12508MNCECE

Micronucleated Cells/Total Cells


0.66%
0.660.66%2022-05-25